Chargement en cours...
Nivolumab infusion reaction manifesting as plantar erythema and pulmonary infiltrate in a lung cancer patient
Infusion reaction is an adverse event of therapeutic monoclonal antibodies. Nivolumab, an anti‐programmed death‐1 antibody, directly activates T cells, which could probably interact with endothelial cells. The etiology of infusion reaction induced by nivolumab may differ from that of other antibodie...
Enregistré dans:
| Publié dans: | Thorac Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons Australia, Ltd
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5668487/ https://ncbi.nlm.nih.gov/pubmed/28845909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12494 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|